FLEXISEQ Logo (WIPO, 27.11.2014)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke FLEXISEQ wurde als Wortmarke am 27.11.2014 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1275754 |
| Registernummer | UK00002585425 |
| Länder | 
|
| Basismarke |
Nr. UK00002585425,
23. September 2011
|
| Anmeldedatum | 27. November 2014 |
| Ablaufdatum | 27. November 2024 |
Markeninhaber
4th floor,
Reading Bridge House,
GB
Reading Bridge House,
GB
Markenvertreter
Bedford House, John Street
London WC1N 2BF
GB
Waren und Dienstleistungen
05
Pharmaceutical preparations and substances; veterinary and
sanitary preparations and substances; chemical preparations
for pharmaceutical purposes; diagnostic preparations and
substances, all for in vivo use; pharmaceuticals in the
field of osteoarthritis, oncology, cardiovascular disease,
respiratory disease, inflammation, infection,
gastrointestinal diseases and central nervous system
diseases; diagnostic preparations for medical and veterinary
use; topical and parenteral preparations incorporating
vesicles; chemical preparations in the form of vesicles for
medical and veterinary purposes; chemical membranes and
chemical aggregates for medical and veterinary purposes;
preparations of arachidonic acids; dispersions and dry
preparations of liposomal active substance carriers for
pharmaceutical, cosmetic and veterinary substances;
cosmeceutical preparations for medical use; local
anaesthetics; steroids; anti-inflammatory drugs;
pharmaceuticals for the treatment of nail fungal infections;
vaccines; immunotherapeutic vaccines; lipids for topical and
parenteral use; creams, dispersions, lotions, ointments,
gels, solutions, sprays, lacquers and film forming solution
for the treatment of pain or inflammation; surfactants for
use in the treatment of or prevention of cancer, infectious
disease, fungal diseases, disease caused by parasites, eye
disease, diseases of the central and peripheral nervous
systems, cardiovascular disease, diseases affecting the
immune system, inflammatory diseases, inherited disease,
single gene disorders, diseases of the mouth, teeth, skin,
hair and ear, bone and blood diseases and reproductive
system disorders, the treatment of inflammation, asthma,
atopic eczema, dishydrotic hand eczema, plaque type
psoriasis, seborrhoeic eczema, acne vulgaris, bronchospasm,
atherothrombotic cardiovascular disorders, venous thrombotic
disorders, pain, dysmenorrhea, hypercholesterolemia,
hypertriglyceridemia, fatty acid metabolism, metal or other
toxicity, Alzheimer's disease, gout or macular degeneration,
such as AMD, or fungal infection and disorders related to
fatty acid deficiencies
10
Medical devices for topical use in the treatment of pain;
molecular filtering devices for medical use; medical,
veterinary and surgical apparatus, instruments and devices;
inhalers; injection apparatus, instruments and devices;
apparatus, instruments and devices for dispensing medical,
surgical and veterinary preparations, dispersions, creams,
powders, tablets and pills; instruments and devices for the
administration of pain relief therapy and prophylaxis
preparations and substances; parts and fittings for all of
the aforesaid
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 09. Mai 2019 | 2019/21 Gaz | PH | RAW: Total Invalidation |
| 17. März 2016 | 2016/18 Gaz | PH | Ablehnung |
| 27. November 2014 | 2015/46 Gaz | GB | Eintragung |
ID: 141275754